Sep 21, 2022, 09:45 AM by

Basepair™, The First Point and Click NGS Analysis & Visualization Platform of It's Kind is Now Available in AWS Marketplace

Sep 21, 2022, 09:45 AM by

Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) and is installing the largest commercial platform of the Olink® technology in the Americas outside of Olink itself to become a leading global certified service provider for the Olink Proximity Extension Assay (PEA) technology, a unique anti-body based proteomic technology.

Sep 21, 2022, 09:44 AM by

Curebase, a company committed to democratizing access to clinical studies, today announced it is partnering with Meru Health on a three-year clinical trial to determine the effectiveness of the online mental healthcare provider’s 12-week treatment program for reducing depression among primary care patients.

Sep 21, 2022, 01:00 AM by User Not Found

Bio-IT World | Bio-IT World is heading to Berlin next month to explore biotech advancements happening in Europe. With five conference tracks, a plenary program, and an exhibit hall we are making the most of the packed two days of scientific content and industry best practices. Here are just a few of the presentations and themes flagged thus far.

Sep 20, 2022, 10:22 AM by

VERICHEM LABORATORIES now offers a liquid stable and ready-to-use set of clinical reference materials for use with the clinical testing of Lactate.

Sep 20, 2022, 10:19 AM by

Sep 20, 2022, 10:19 AM by

Sep 20, 2022, 10:18 AM by

Sep 20, 2022, 10:18 AM by

VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development.

Sep 20, 2022, 01:00 AM by User Not Found

Bio-IT World | Tel Aviv University researchers discovered that glioblastoma cells—a highly resistant, aggressive, and deadly form of cancer—“starve” to death without immunometabolic support from astrocytes.

Sep 19, 2022, 10:26 AM by

Sep 16, 2022, 10:08 AM by

Sep 15, 2022, 11:05 AM by

Sep 15, 2022, 11:03 AM by

The Taiwan Food and Drug Administration has granted CTL Amedica Corporation a license to market the MATISSE Anterior Cervical Interbody Fusion (ACIF) Cage System.

Sep 15, 2022, 11:02 AM by

Sep 15, 2022, 10:52 AM by

Sep 15, 2022, 10:36 AM by

Sep 15, 2022, 10:35 AM by

Sep 15, 2022, 10:35 AM by

Sep 15, 2022, 10:34 AM by